AMPEL BioSolutions Company

AMPEL is a precision medicine company commercializing LDTs that predict disease status, molecular pathways, and best drug options.

Last Funding Type: Debt Financing
Funding Status: Seed
Headquarters: Charlottesville, Virginia, United States
Founded Date: 2013-07-13
Last Funding Date: 2022-12-13
Total Funding: 12510000.0
Technology: Data-driven Technologies
Employee Number: 11-50
Estimated Revenue: $1M to $10M
Investors Number: 1.0
Industry: Clinical Development